Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy

Name: Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy
Published: 2013
License: Public Domain

GlaxoSmithKline · 2013

ClinicalTrials.gov · Datasets · License: Public Domain · 2013

Open Source ↗

efficacy glomerulonephritis placebo safety

glomerulonephritis, membranous, benlysta, efficacy, proteinuria, idiopathic membranous nephropathy, gsk1550188, anti-phospholipase a2 receptor antibodies, safety, placebo, blys, belimumab, lymphostat-b

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 840191
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.